NNN — Nanosynth Income Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
R2017 December 31st | R2018 December 31st | 2019 December 31st | R2020 December 31st | 2021 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.789 | 0 | 0.053 | 0.001 | 0.209 |
Cost of Revenue | |||||
Gross Profit | 0.34 | 0 | 0.026 | -0.014 | 0.045 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2.94 | 0.668 | 0.761 | 0.965 | 3.39 |
Operating Profit | -2.15 | -0.668 | -0.709 | -0.965 | -3.18 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -2.23 | -0.714 | -0.712 | -0.969 | -3.18 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.9 | -0.775 | -0.592 | -0.969 | -3.18 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -1.9 | -1.06 | -1.55 | -1.42 | -3.34 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.9 | -1.06 | -1.55 | -1.42 | -3.34 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.017 | -0.002 | -0.001 | -0.001 | -0.001 |